News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,314 Results
Type
Article (44247)
Company Profile (166)
Press Release (549892)
Multimedia
Podcasts (155)
Webinars (20)
Section
Business (163980)
Career Advice (1645)
Deals (28329)
Drug Delivery (149)
Drug Development (75187)
Employer Resources (123)
FDA (12952)
Job Trends (11422)
News (285339)
Policy (26698)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1882)
Accelerated approval (47)
ADA (40)
Adcomms (35)
Allergies (171)
Alliances (44055)
ALS (194)
Alzheimer's disease (1530)
Antibody-drug conjugate (ADC) (485)
Approvals (13322)
Artificial intelligence (549)
ASCO (298)
Autoimmune disease (319)
Automation (36)
Bankruptcy (253)
Best Places to Work (8301)
BIO (47)
BIOSECURE Act (20)
Biosimilars (233)
Biotechnology (81)
Bladder cancer (173)
Brain cancer (66)
Breast cancer (598)
Cancer (5104)
Cardiovascular disease (452)
Career advice (1396)
Career pathing (47)
CAR-T (325)
CDC (43)
Celiac Disease (2)
Cell therapy (799)
Cervical cancer (40)
Clinical research (66313)
Collaboration (1807)
Commercialization (1)
Company closure (6)
Compensation (850)
Complete response letters (88)
COVID-19 (2427)
CRISPR (91)
C-suite (1053)
Cystic fibrosis (133)
Data (7412)
Decentralized trials (3)
Denatured (33)
Depression (172)
Dermatology (75)
Diabetes (543)
Diagnostics (4274)
Digital health (36)
Diversity (10)
Diversity, equity & inclusion (35)
Drug discovery (304)
Drug pricing (228)
Drug shortages (36)
Duchenne muscular dystrophy (262)
Earnings (62467)
Editorial (71)
Employer branding (16)
Employer resources (117)
Events (95835)
Executive appointments (967)
FDA (16083)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (15)
Frontotemporal dementia (23)
Funding (1439)
Gene editing (196)
Generative AI (51)
Gene therapy (638)
GLP-1 (1123)
Government (3647)
Grass and pollen (6)
Guidances (334)
Healthcare (12099)
Hematology (158)
HIV (79)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (311)
Immuno-oncology (92)
Indications (193)
Infectious disease (2743)
Inflammatory bowel disease (200)
Inflation Reduction Act (13)
Influenza (126)
Intellectual property (255)
Interviews (268)
IPO (11583)
IRA (54)
Job creations (3358)
Job search strategy (1178)
JPM (63)
Kidney cancer (21)
Labor market (96)
Layoffs (530)
Leadership (42)
Legal (6400)
Liver cancer (80)
Longevity (21)
Lung cancer (692)
Lymphoma (453)
Machine learning (44)
Management (44)
Manufacturing (964)
Marketing (3)
MASH (212)
Medical affairs (1)
Medical device (7232)
Medtech (7323)
Mergers & acquisitions (17739)
Metabolic disorders (1553)
mRNA (226)
Multiple sclerosis (184)
NASH (23)
Neurodegenerative disease (390)
Neuropsychiatric disorders (114)
Neuroscience (2989)
Neurotech (1)
NextGen: Class of 2026 (4331)
Non-profit (2531)
Now hiring (67)
Obesity (772)
Opinion (328)
Ovarian cancer (188)
Pain (242)
Pancreatic cancer (256)
Parkinson's disease (349)
Partnered (28)
Patents (507)
Patient recruitment (629)
Peanut (52)
People (54616)
Pharmaceutical (78)
Pharmacy benefit managers (38)
Phase 1 (20629)
Phase 2 (29103)
Phase 3 (22054)
Pipeline (8232)
Policy (332)
Postmarket research (2339)
Preclinical (8022)
Press Release (46)
Prostate cancer (267)
Psychedelics (57)
Radiopharmaceuticals (315)
Rare diseases (1032)
Real estate (4944)
Recruiting (52)
Regulatory (21459)
Reports (34)
Research institute (1803)
Resumes & cover letters (249)
Rett syndrome (22)
RNA editing (22)
RSV (79)
Schizophrenia (181)
Series A (247)
Series B (250)
Service/supplier (9)
Sickle cell disease (112)
Special edition (29)
Spinal muscular atrophy (173)
Sponsored (34)
Startups (3486)
State (2)
Stomach cancer (16)
Supply chain (111)
Tariffs (100)
The Weekly (119)
Vaccines (979)
Venture capital (120)
Weight loss (543)
Women's health (93)
Worklife (17)
Date
Today (33)
Last 7 days (349)
Last 30 days (1873)
Last 365 days (23505)
2026 (12244)
2025 (23819)
2024 (27196)
2023 (30414)
2022 (40199)
2021 (43082)
2020 (39942)
2019 (32460)
2018 (24994)
2017 (27893)
2016 (28791)
2015 (34093)
2014 (27292)
2013 (23381)
2012 (24758)
2011 (24775)
2010 (22583)
Location
Africa (751)
Alabama (65)
Alaska (3)
Arizona (201)
Arkansas (13)
Asia (43101)
Australia (6546)
California (9999)
Canada (3102)
China (1425)
Colorado (438)
Connecticut (418)
Delaware (340)
Europe (87262)
Florida (1583)
Georgia (317)
Hawaii (2)
Idaho (34)
Illinois (881)
India (93)
Indiana (459)
Iowa (13)
Japan (556)
Kansas (116)
Kentucky (39)
Louisiana (32)
Maine (31)
Maryland (1173)
Massachusetts (7530)
Michigan (213)
Minnesota (528)
Mississippi (5)
Missouri (84)
Montana (24)
Nebraska (21)
Nevada (114)
New Hampshire (34)
New Jersey (3064)
New Mexico (25)
New York (2771)
North Carolina (1409)
North Dakota (4)
Northern California (5058)
Ohio (270)
Oklahoma (13)
Oregon (31)
Pennsylvania (1958)
Puerto Rico (31)
Rhode Island (37)
South America (1056)
South Carolina (42)
South Dakota (1)
Southern California (4038)
Tennessee (121)
Texas (1485)
United States (36025)
Utah (233)
Vermont (1)
Virginia (282)
Washington D.C. (70)
Washington State (860)
West Virginia (2)
Wisconsin (93)
Wyoming (1)
594,314 Results for "pharma two b ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
China’s Haisco Pharmaceutical continues to wield deals, this time out-licensing rights to two late-stage programs to New Jersey biotech Nuvectis.
June 22, 2026
·
2 min read
·
Gabrielle Masson
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
Biopharmas that announced Series B financing this year and are looking for employees as they grow include two companies that received $100 million or more. One has partnerships with three Big Pharmas.
June 18, 2026
·
4 min read
·
Angela Gabriel
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
February 26, 2026
·
8 min read
Press Releases
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
June 22, 2026
·
6 min read
Press Releases
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
June 17, 2026
·
1 min read
Press Releases
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
May 10, 2026
·
3 min read
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
April 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
COUR Pharma Announces Closing of $50 Million Series B
June 18, 2026
·
2 min read
Business
Lilly is pharma’s top dog, placing first in innovation and invention: IDEA
Eli Lilly is the first pharma company to take first place in both categories in the eight years that intelligence firm IDEA Pharma has put out its analysis. Skyrocketing sales and multiple FDA approvals helped the company shoot to the top.
May 26, 2026
·
2 min read
·
Tristan Manalac
1 of 59,432
Next
